Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

Prognostic classifications for patients treated with sorafenib for hepatocellular carcinoma (HCC) facilitate stratification in trials and inform clinical decision making. Recently, 3 different prognostic models (hepatoma arterial-embolization prognosis [HAP] score, sorafenib advanced HCC prognosis [...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Transl Gastroenterol
Hlavní autoři: Sansone, Vito, Tovoli, Francesco, Casadei-Gardini, Andrea, Di Costanzo, Giovan Giuseppe, Magini, Giulia, Sacco, Rodolfo, Pressiani, Tiziana, Trevisani, Franco, Rimini, Margherita, Tortora, Raffaella, Nardi, Elena, Ielasi, Luca, Piscaglia, Fabio, Granito, Alessandro
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7808555/
https://ncbi.nlm.nih.gov/pubmed/33443944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000286
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky